35.00
+0.40
+(1.16%)
At close: April 17 at 8:01:18 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in TWD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 5 | 4 |
| Avg. Estimate | 56.11B | 56.87B | 233.98B | 236.63B |
| Low Estimate | 56.11B | 56.87B | 232.3B | 235.91B |
| High Estimate | 56.11B | 56.87B | 236.74B | 237.47B |
| Year Ago Sales | 54.12B | 55.61B | 230.03B | 233.98B |
| Sales Growth (year/est) | 3.68% | 2.25% | 1.72% | 1.13% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CHWD.F | -- | -- | -- | -- |
| S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
| Downgrade | HSBC: Hold to Reduce | 11/1/2018 |
| Upgrade | UBS: Neutral to Buy | 5/3/2016 |
| Downgrade | Citigroup: Buy to Neutral | 4/28/2016 |
| Upgrade | HSBC: Reduce to Hold | 4/22/2016 |
| Downgrade | Credit Suisse: Neutral to Underperform | 2/8/2012 |